These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28554721)

  • 1. Current and emerging comorbidities in cystic fibrosis.
    Ronan NJ; Elborn JS; Plant BJ
    Presse Med; 2017 Jun; 46(6 Pt 2):e125-e138. PubMed ID: 28554721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnosis of cystic fibrosis.
    De Boeck K; Vermeulen F; Dupont L
    Presse Med; 2017 Jun; 46(6 Pt 2):e97-e108. PubMed ID: 28576637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of the pulmonary and extrapulmonary manifestations of cystic fibrosis.
    Chin M; Aaron SD; Bell SC
    Presse Med; 2017 Jun; 46(6 Pt 2):e139-e164. PubMed ID: 28576636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New treatments targeting the basic defects in cystic fibrosis.
    Fajac I; Wainwright CE
    Presse Med; 2017 Jun; 46(6 Pt 2):e165-e175. PubMed ID: 28554723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ageing with cystic fibrosis: Classical and emerging comorbidities in adults with cystic fibrosis].
    Regard L; Lafoeste H; Martin C; Chassagnon G; Burgel PR
    Rev Pneumol Clin; 2018 Oct; 74(5):279-291. PubMed ID: 30316653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The changing epidemiology and demography of cystic fibrosis.
    Stephenson AL; Stanojevic S; Sykes J; Burgel PR
    Presse Med; 2017 Jun; 46(6 Pt 2):e87-e95. PubMed ID: 28554720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.
    Siryani I; Jama M; Rumman N; Marzouqa H; Kannan M; Lyon E; Hindiyeh M
    PLoS One; 2015; 10(7):e0133890. PubMed ID: 26208274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal screening for cystic fibrosis: long-term clinical balance.
    Mastella G; Zanolla L; Castellani C; Altieri S; Furnari M; Giglio L; Lombardo M; Miano A; Sciuto C; Pardo F; Magazzù G
    Pancreatology; 2001; 1(5):531-7. PubMed ID: 12120233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis.
    Lavie M; Manovitz T; Vilozni D; Levy-Mendelovich S; Sarouk I; Weintraubv I; Shoseyov D; Cohen-Cymberknoh M; Rivlin J; Efrati O
    World J Gastroenterol; 2015 Jan; 21(1):318-25. PubMed ID: 25574107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demographics of the UK cystic fibrosis population: implications for neonatal screening.
    McCormick J; Green MW; Mehta G; Culross F; Mehta A
    Eur J Hum Genet; 2002 Oct; 10(10):583-90. PubMed ID: 12357328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [News in cystic fibrosis].
    Delaisi B
    Rev Pneumol Clin; 2013 Aug; 69(4):225-8. PubMed ID: 23856023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects.
    Kuk K; Taylor-Cousar JL
    Ther Adv Respir Dis; 2015 Dec; 9(6):313-26. PubMed ID: 26416827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized medicine in cystic fibrosis: dawning of a new era.
    Clancy JP; Jain M
    Am J Respir Crit Care Med; 2012 Oct; 186(7):593-7. PubMed ID: 22723294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic Fibrosis Diagnosis and Newborn Screening.
    Rosenfeld M; Sontag MK; Ren CL
    Pediatr Clin North Am; 2016 Aug; 63(4):599-615. PubMed ID: 27469178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
    Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
    BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CF versus CRMS: diagnostic challenges in cystic fibrosis.
    Temme R; Roggenbuck J; McNamara J
    Minn Med; 2012 Oct; 95(10):42-4. PubMed ID: 23193705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiologic study of the cystic fibrosis gene in the Champagne-Ardenne region].
    Clavel C; Pennaforte F; Pigeon F; Mozelle M; Boutterin MC; Duval-Binninger I; F-erec C; Birembaut P
    Ann Biol Clin (Paris); 1996; 54(2):67-74. PubMed ID: 8763629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New therapies for cystic fibrosis targeting the CFTR gene or the CFTR protein].
    Hubert D; Bui S; Marguet C; Colomb-Jung V; Murris-Espin M; Corvol H; Munck A
    Rev Mal Respir; 2016 Oct; 33(8):658-665. PubMed ID: 26806675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fibrosis transmembrane conductance regulator-modifying medications: the future of cystic fibrosis treatment.
    Pettit RS
    Ann Pharmacother; 2012; 46(7-8):1065-75. PubMed ID: 22739718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ivacaftor: the first therapy acting on the primary cause of cystic fibrosis.
    McPhail GL; Clancy JP
    Drugs Today (Barc); 2013 Apr; 49(4):253-60. PubMed ID: 23616952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.